This is in line with the fact that decreased stromal AR expression in PCa is associated with earlier disease progression and BCR, thus suggesting an antitumorigenic role of stromal AR during the early, hormone-naïve stages of PCa [142,143,144]. This evidence concerns the gene BCR and posterior cortical atrophy.